Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

Back to Agenda

Regulatory Affairs: Part 6: Interactions with FDA

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

Regulatory Affairs: Part 6: Interactions with FDA

Have an account?

Regulatory Affairs: The IND, NDA, and Post-Marketing

Regulatory Affairs: Part 6: Interactions with FDA

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Be informed and stay engaged.